Cipla | CIPLA - 当期純利益

株価
1,364.40
毎日の変更
30.70 2.30%
毎月
13.47%
毎年
-9.57%
Q2 予測
1,280.53




当期純利益 変化する 日付
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD 24.56M 50.3M 2025-12
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -5.53M 621K 2025-09
Cipla INR 6.76B 6.75B 2025-12
Dr.Reddys Laboratories INR 12.1B 2.27B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sun Pharmaceuticals INR 33.69B 2.51B 2025-12
TherapeuticsMD USD -1.09M 356K 2024-06
UPL INR 3.96B 1.57B 2025-12